| Followers | 3804 |
| Posts | 244703 |
| Boards Moderated | 0 |
| Alias Born | 07/30/2007 |
Thursday, August 05, 2021 12:34:35 PM
Shorts will be in big trouble ahead they lied for 2 days about an offering coming that is the only reason we did not close over $40.00 yesterday. Today in he CEO interview on Behzinga she confirmed over 91 million in cash enough through next June. No offering. Now we have to set up for the next big run in the days ahead they had shorted us so low.
BYSI
BYSI
Recent BYSI News
- BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026 • GlobeNewswire Inc. • 06/02/2026 11:00:00 AM
- BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 05/18/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:13:11 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:00:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:30:42 PM
- BeyondSpring shares rise after narrower quarterly loss and pipeline advances (BYSI) • IH Market News • 05/13/2026 01:29:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:00:21 AM
- BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2026 11:00:00 AM
- BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:57:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:24 PM
- BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:36:23 PM
- BeyondSpring Files 2025 Annual Report on Form 10-K • GlobeNewswire Inc. • 03/25/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 12:30:13 PM
- BeyondSpring Reports 2025 Year-End Financial Results • GlobeNewswire Inc. • 03/25/2026 12:30:00 PM
- BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference • GlobeNewswire Inc. • 02/09/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 09:30:28 PM
- BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path • GlobeNewswire Inc. • 12/12/2025 12:00:00 PM
- BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 • GlobeNewswire Inc. • 12/11/2025 12:00:00 PM
